
6 others would like to attend.
Register Now
Event info
This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.
EDUCATIONAL OBJECTIVES
After attending this live internet activity, participants should be able to:
- Identify the steps required to accomplish eradication of chronic viral hepatitis by 2030.
- Review current knowledge of NAFLD and non-alcoholic steatohepatitis and explore the use of new agents and approaches to treatment of the conditions.
- Integrate the algorithm for a therapeutic approach to treatment of HBV using anti-virals.
- Discuss diagnosis, management and treatment unusual hepatitis virus infections.
- Update the skills and management required for transplant hepatology.
- Apply current options of therapy for hepatocellular carcinoma to determine the best approach for your patients.
- Describe the diagnosis and treatment of PBC and PSC.
- Integrate treatment options discussed for patients with ESLD due to alcohol who have complicating factors such as HCV, NASH or inherited genetic disorders.
- Discuss the issues complicating drug treatment in decompensated cirrhosis, hepatic encephalopathy and hyponatremia.
- Update the diagnosis and management benign masses in the liver.
- Discuss the rising burden of alcoholic liver disease in the United States.
- Discuss advances in treatment of acute liver failure.
ACCREDITATION
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
For more information please visit the official event page.
6 others would like to attend.
Register Now